The presence of portal vein thrombosis (PVT) is still considered by many transplantation centers to be an absolute contraindication to liver transplantation because of the technical difficulties that it can present and its association with a higher rate of patient morbidity and mortality. Renoportal bypass (RPB) can help to remove these barriers. This study describes our institution's experience with RPB through the description of a new and successful simplified surgical strategy, a patient and graft outcome analysis, intraoperative vascular flow measurements, and the use of splenic artery embolization (SAE) as an effective adjunct for treating sporadic cases of unrelieved portal hypertension. Between January 2004 and January 2013, 10 patients with grade 4 PVT underwent RPB. At the last follow-up (42.2 6 21.1 months), the patient and graft survival rates were 100%. Five patients (50%) experienced posttransplant ascites, and 2 of those underwent proximal SAE to modulate the liver inflow and overcome the ascites. Three patients (30%) experienced transient kidney injury in the early posttransplant period and were treated efficiently with medical therapy. The renoportal flows were close to the desirable 100 mL/100 g of liver tissue in all cases. The experience and data support RPB as a feasible and easily reproducible technique without the risks and technical challenges associated with the tedious dissection of a cavernous hilum.
See Editorial on Page 275Portal vein thrombosis (PVT) is a well-recognized complication in patients with cirrhosis, with a reported incidence ranging between 5% and 15%.1 At one time, the presence of PVT was considered an absolute contraindication to liver transplantation (LT) because of the technical difficulties that it can present during transplantation and its association with a higher rate of patient morbidity and mortality. These difficulties include excessive bleeding and the inability to establish adequate portal blood flow, which results in allograft dysfunction. Although experience and improved surgical techniques have helped to reduce the occurrence of these complications and have enabled patients with PVT to undergo successful transplantation, surgical complexity and perioperative morbidity and mortality rates persist as barriers to transplantation for these patients at many institutions. Renoportal bypass (RPB) can help to remove these barriers by reducing surgical complexity and improving perioperative outcomes for transplant recipients with PVT and a concomitant splenorenal shunt (SRS).This study describes our institution's experience with RPB. RPB was described a decade ago by Kato